The Dopamine Transporter is Decreased in the Striatum of Subjects with Restless Legs Syndrome
Author(s) -
Christopher J. Earley,
Hiroto Kuwabara,
Dean F. Wong,
Charlene E. Gamaldo,
Rachel Marie E. Salas,
James Robert Bras̆ić,
Hayden T. Ravert,
Robert F. Dannals,
Richard P. Allen
Publication year - 2011
Publication title -
sleep
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.222
H-Index - 207
eISSN - 1550-9109
pISSN - 0161-8105
DOI - 10.1093/sleep/34.3.341
Subject(s) - dopamine transporter , restless legs syndrome , putamen , striatum , dopamine , medicine , psychology , endocrinology , dopaminergic , neuroscience , neurology
Prior studies, all using SPECT techniques, failed to find any differences for dopamine transporter (DAT) in restless legs syndrome (RLS) subjects. The distinct pharmacokinetic properties associated with SPECT-determined DAT along with rapid biodynamic changes in DAT may, however, have missed membrane-bound DAT differences. The current studies assessed real-time DAT binding potentials (BP) in striatum of RLS patients using (11)C-methylphenidate and PET techniques.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom